These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3499427

  • 1. Human leukemia cell binding and killing by anti-CD5 radioimmunotoxins.
    Buchsbaum DJ, Nelson LA, Hanna DE, Vallera DA.
    Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1701-12. PubMed ID: 3499427
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic effects of anti-CD5 radioimmunotoxins on human tumors in vitro and in a nude mouse model.
    Manske JM, Buchsbaum DJ, Hanna DE, Vallera DA.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7107-14. PubMed ID: 2461252
    [Abstract] [Full Text] [Related]

  • 3. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA.
    Blood; 1985 Sep 15; 66(3):627-35. PubMed ID: 3896347
    [Abstract] [Full Text] [Related]

  • 4. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC, Youle RJ, Vallera DA.
    Cancer Res; 1984 Jul 15; 44(7):3000-6. PubMed ID: 6372999
    [Abstract] [Full Text] [Related]

  • 5. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM, Buchsbaum DJ, Azemove SM, Hanna DE, Vallera DA.
    J Immunol; 1986 Jun 15; 136(12):4721-8. PubMed ID: 3086441
    [Abstract] [Full Text] [Related]

  • 6. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
    Ito T, Qiu H, Collins JA, Brill AB, Johnson DK, Griffin TW.
    Cancer Res; 1991 Jan 01; 51(1):255-60. PubMed ID: 1988087
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G, Runge W, Jansen FK, Vallera DA.
    Cancer Res; 1985 Mar 01; 45(3):1328-36. PubMed ID: 3971376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr 01; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 10. Four ricin chain A-based immunotoxins directed against the common chronic lymphocytic leukemia antigen: in vitro characterization.
    Faguet GB, Agee JF.
    Blood; 1993 Jul 15; 82(2):536-43. PubMed ID: 7687163
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B, Vallera DA, Jaszcz WB, Nguyen D, Kersey JH.
    Cancer Res; 1992 Mar 01; 52(5):1314-21. PubMed ID: 1371092
    [Abstract] [Full Text] [Related]

  • 12. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML, Lambert JM, Goldmacher VS, Blättler WA, Nadler LM.
    Cancer Res; 1992 Aug 01; 52(15):4200-7. PubMed ID: 1379121
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells.
    Ravel S, Colombatti M, Casellas P.
    Blood; 1992 Mar 15; 79(6):1511-7. PubMed ID: 1372189
    [Abstract] [Full Text] [Related]

  • 15. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA.
    J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241
    [Abstract] [Full Text] [Related]

  • 16. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
    Youle RJ, Uckun FM, Vallera DA, Colombatti M.
    J Immunol; 1986 Jan 15; 136(1):93-8. PubMed ID: 3079613
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
    Preijers FW, De Witte T, Wessels JM, Meyerink JP, Haanen C, Capel PJ.
    Br J Haematol; 1989 Feb 15; 71(2):195-201. PubMed ID: 2784323
    [Abstract] [Full Text] [Related]

  • 20. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
    Ma D, McDevitt MR, Barendswaard E, Lai L, Curcio MJ, Pellegrini V, Brechbiel MW, Scheinberg DA.
    Leukemia; 2002 Jan 15; 16(1):60-6. PubMed ID: 11840264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.